{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:36:49Z","timestamp":1787002609032,"version":"build-2736575974"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,9,28]],"date-time":"2010-09-28T00:00:00Z","timestamp":1285632000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1038\/nrneph.2010.122","type":"journal-article","created":{"date-parts":[[2010,9,28]],"date-time":"2010-09-28T06:21:57Z","timestamp":1285654917000},"page":"736-743","source":"Crossref","is-referenced-by-count":28,"title":["Living donor kidney transplantation in patients with hereditary nephropathies"],"prefix":"10.1038","volume":"6","author":[{"given":"Patrick","family":"Niaudet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,28]]},"reference":[{"key":"BFnrneph2010122_CR1","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1681\/ASN.2004100824","volume":"16","author":"CL Davis","year":"2005","unstructured":"Davis, C. L. & Delmonico, F. L. Living-donor kidney transplantation: a review of the current practices for the live donor. J. Am. Soc. Nephrol. 16, 2098\u20132110 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010122_CR2","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1056\/NEJM200103083441004","volume":"344","author":"KC Mange","year":"2001","unstructured":"Mange, K. C., Joffe, M. M. & Feldman, H. I. Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. N. Engl. J. Med. 344, 726\u2013731 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2010122_CR3","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1681\/ASN.V7112288","volume":"7","author":"BL Kasiske","year":"1996","unstructured":"Kasiske, B. L. et al. The evaluation of living renal transplant donors: clinical practice guidelines. Ad Hoc Clinical Practice Guidelines Subcommittee of the Patient Care and Education Committee of the American Society of Transplant Physicians. J. Am. Soc. Nephrol. 7, 2288\u20132313 (1996).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010122_CR4","doi-asserted-by":"publisher","first-page":"E22","DOI":"10.1053\/ajkd.2002.36938","volume":"40","author":"RL Donne","year":"2002","unstructured":"Donne, R. L. et al. Recurrence of hemolytic uremic syndrome after live related renal transplantation associated with subsequent de novo disease in the donor. Am. J. Kidney Dis. 40, E22 (2002).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2010122_CR5","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1056\/NEJMcp0804458","volume":"359","author":"JJ Grantham","year":"2008","unstructured":"Grantham, J. J. Clinical practice. Autosomal dominant polycystic kidney disease. N. Engl. J. Med. 359, 1477\u20131485 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2010122_CR6","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","volume":"369","author":"VE Torres","year":"2007","unstructured":"Torres, V. E., Harris, P. C. & Pirson, Y. Autosomal dominant polycystic kidney disease. Lancet 369, 1287\u20131301 (2007).","journal-title":"Lancet"},{"key":"BFnrneph2010122_CR7","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1053\/j.ackd.2010.01.002","volume":"17","author":"AR Gallagher","year":"2010","unstructured":"Gallagher, A. R., Germino, G. G. & Somlo, S. Molecular advances in autosomal dominant polycystic kidney disease. Adv. Chronic Kidney Dis. 17, 118\u2013130 (2010).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"BFnrneph2010122_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0140-6736(98)03495-3","volume":"353","author":"N Hateboer","year":"1999","unstructured":"Hateboer, N. et al. Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Lancet 353, 103\u2013107 (1999).","journal-title":"Lancet"},{"key":"BFnrneph2010122_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/ajmg.1320180108","volume":"18","author":"JC Bear","year":"1984","unstructured":"Bear, J. C. et al. Age at clinical onset and at ultrasonographic detection of adult polycystic kidney disease: data for genetic counselling. Am. J. Med. Genet. 18, 45\u201353 (1984).","journal-title":"Am. J. Med. Genet."},{"key":"BFnrneph2010122_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1148\/radiology.213.1.r99oc05273","volume":"213","author":"C Nicolau","year":"1999","unstructured":"Nicolau, C. et al. Autosomal dominant polycystic kidney disease types 1 and 2: assessment of US sensitivity for diagnosis. Radiology 213, 273\u2013276 (1999).","journal-title":"Radiology"},{"key":"BFnrneph2010122_CR11","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S0140-6736(94)92026-5","volume":"343","author":"D Ravine","year":"1994","unstructured":"Ravine, D. et al. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 343, 824\u2013827 (1994).","journal-title":"Lancet"},{"key":"BFnrneph2010122_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1681\/ASN.2008050507","volume":"20","author":"Y Pei","year":"2009","unstructured":"Pei, Y. et al. Unified criteria for ultrasonographic diagnosis of ADPKD. J. Am. Soc. Nephrol. 20, 205\u2013212 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010122_CR13","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1053\/ajkd.2001.22089","volume":"37","author":"MS Zand","year":"2001","unstructured":"Zand, M. S. et al. Screening a living kidney donor for polycystic kidney disease using heavily T2-weighted MRI. Am. J. Kidney Dis. 37, 612\u2013619 (2001).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2010122_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/TP.0b013e318191965d","volume":"87","author":"JD Blumenfeld","year":"2009","unstructured":"Blumenfeld, J. D. Pretransplant genetic testing of live kidney donors at risk for autosomal dominant polycystic kidney disease. Transplantation 87, 6\u20137 (2009).","journal-title":"Transplantation"},{"key":"BFnrneph2010122_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/TP.0b013e318191e729","volume":"87","author":"E Huang","year":"2009","unstructured":"Huang, E. et al. DNA testing for live kidney donors at risk for autosomal dominant polycystic kidney disease. Transplantation 87, 133\u2013137 (2009).","journal-title":"Transplantation"},{"key":"BFnrneph2010122_CR16","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1046\/j.1523-1755.2002.00326.x","volume":"61","author":"S Rossetti","year":"2002","unstructured":"Rossetti, S. et al. A complete mutation screen of the ADPKD genes by DHPLC. Kidney Int. 61, 1588\u20131599 (2002).","journal-title":"Kidney Int."},{"key":"BFnrneph2010122_CR17","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1086\/515497","volume":"61","author":"B Veldhuisen","year":"1997","unstructured":"Veldhuisen, B. et al. A spectrum of mutations in the second gene for autosomal dominant polycystic kidney disease (PKD2). Am. J. Hum. Genet. 61, 547\u2013555 (1997).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneph2010122_CR18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/ajmg.1320440404","volume":"44","author":"VL Hannig","year":"1992","unstructured":"Hannig, V. L., Erickson, S. M. & Phillips, J. A. 3rd. Utilization and evaluation of living-related donors for patients with adult polycystic kidney disease. Am. J. Med. Genet. 44, 409\u2013412 (1992).","journal-title":"Am. J. Med. Genet."},{"key":"BFnrneph2010122_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrneph.2010.18","volume":"6","author":"PC Harris","year":"2010","unstructured":"Harris, P. C. & Rossetti, S. Molecular diagnostics for autosomal dominant polycystic kidney disease. Nat. Rev. Nephrol. 6, 197\u2013206 (2010).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrneph2010122_CR20","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1681\/ASN.2008090984","volume":"20","author":"L Heidet","year":"2009","unstructured":"Heidet, L. & Gubler, M. C. The renal lesions of Alport syndrome. J. Am. Soc. Nephrol. 20, 1210\u20131215 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010122_CR21","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1681\/ASN.V991736","volume":"9","author":"CE Kashtan","year":"1998","unstructured":"Kashtan, C. E. Alport syndrome and thin glomerular basement membrane disease. J. Am. Soc. Nephrol. 9, 1736\u20131750 (1998).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010122_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/ki.1993.8","volume":"43","author":"K Tryggvason","year":"1993","unstructured":"Tryggvason, K., Zhou, J., Hostikka, S. L. & Shows, T. B. Molecular genetics of Alport syndrome. Kidney Int. 43, 38\u201344 (1993).","journal-title":"Kidney Int."},{"key":"BFnrneph2010122_CR23","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1126\/science.2349482","volume":"248","author":"DF Barker","year":"1990","unstructured":"Barker, D. F. et al. Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 248, 1224\u20131227 (1990).","journal-title":"Science"},{"key":"BFnrneph2010122_CR24","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1097\/01.ASN.0000090034.71205.74","volume":"14","author":"JP Jais","year":"2003","unstructured":"Jais, J. P. et al. X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a \u201cEuropean Community Alport Syndrome Concerted Action\u201d study. J. Am. Soc. Nephrol. 14, 2603\u20132610 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010122_CR25","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1681\/ASN.V9122291","volume":"9","author":"P Martin","year":"1998","unstructured":"Martin, P. et al. High mutation detection rate in the COL4A5 collagen gene in suspected Alport syndrome using PCR and direct DNA sequencing. J. Am. Soc. Nephrol. 9, 2291\u20132301 (1998).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010122_CR26","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1681\/ASN.V75702","volume":"7","author":"N Heiskari","year":"1996","unstructured":"Heiskari, N. et al. Identification of 17 mutations in ten exons in the COL4A5 collagen gene, but no mutations found in four exons in COL4A6: a study of 250 patients with hematuria and suspected of having Alport syndrome. J. Am. Soc. Nephrol. 7, 702\u2013709 (1996).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010122_CR27","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/ki.1985.63","volume":"27","author":"J Feingold","year":"1985","unstructured":"Feingold, J. et al. Genetic heterogeneity of Alport syndrome. Kidney Int. 27, 672\u2013677 (1985).","journal-title":"Kidney Int."},{"key":"BFnrneph2010122_CR28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1681\/ASN.V12197","volume":"12","author":"L Heidet","year":"2001","unstructured":"Heidet, L. et al. Structure of the human type IV collagen gene COL4A3 and mutations in autosomal Alport syndrome. J. Am. Soc. Nephrol. 12, 97\u2013106 (2001).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010122_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/ng0994-77","volume":"8","author":"T Mochizuki","year":"1994","unstructured":"Mochizuki, T. et al. Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome. Nat. Genet. 8, 77\u201381 (1994).","journal-title":"Nat. Genet."},{"key":"BFnrneph2010122_CR30","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1093\/ndt\/gfh435","volume":"19","author":"R Torra","year":"2004","unstructured":"Torra, R., Tazon-Vega, B., Ars, E. & Ballarin, J. Collagen type IV (\u03b13- \u03b14) nephropathy: from isolated haematuria to renal failure. Nephrol. Dial. Transplant. 19, 2429\u20132432 (2004).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2010122_CR31","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1111\/j.1523-1755.2004.00560.x","volume":"65","author":"C Pescucci","year":"2004","unstructured":"Pescucci, C. et al. Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene. Kidney Int. 65, 1598\u20131603 (2004).","journal-title":"Kidney Int."},{"key":"BFnrneph2010122_CR32","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1111\/j.1523-1755.2000.00358.x","volume":"58","author":"FT van der Loop","year":"2000","unstructured":"van der Loop, F. T. et al. Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation. Kidney Int. 58, 1870\u20131875 (2000).","journal-title":"Kidney Int."},{"key":"BFnrneph2010122_CR33","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1681\/ASN.V114649","volume":"11","author":"JP Jais","year":"2000","unstructured":"Jais, J. P. et al. X-linked Alport syndrome: natural history in 195 families and genotype-phenotype correlations in males. J. Am. Soc. Nephrol. 11, 649\u2013657 (2000).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010122_CR34","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1136\/jmg.34.4.326","volume":"34","author":"F Flinter","year":"1997","unstructured":"Flinter, F. Alport's syndrome. J. Med. Genet. 34, 326\u2013330 (1997).","journal-title":"J. Med. Genet."},{"key":"BFnrneph2010122_CR35","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3109\/13816819709057125","volume":"18","author":"D Colville","year":"1997","unstructured":"Colville, D. et al. Ocular manifestations of autosomal recessive Alport syndrome. Ophthalmic Genet. 18, 119\u2013128 (1997).","journal-title":"Ophthalmic Genet."},{"key":"BFnrneph2010122_CR36","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1093\/ndt\/gfn779","volume":"24","author":"CE Kashtan","year":"2009","unstructured":"Kashtan, C. E. Women with Alport syndrome: risks and rewards of kidney donation. Nephrol. Dial. Transplant. 24, 1369\u20131370 (2009).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2010122_CR37","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1093\/ndt\/gfn635","volume":"24","author":"O Gross","year":"2009","unstructured":"Gross, O., Weber, M., Fries, J. W. & Muller, G. A. Living donor kidney transplantation from relatives with mild urinary abnormalities in Alport syndrome: long-term risk, benefit and outcome. Nephrol. Dial. Transplant. 24, 1626\u20131630 (2009).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrneph2010122_CR38","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1681\/ASN.V1351248","volume":"13","author":"C Badenas","year":"2002","unstructured":"Badenas, C. et al. Mutations in the COL4A4 and COL4A3 genes cause familial benign hematuria. J. Am. Soc. Nephrol. 13, 1248\u20131254 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010122_CR39","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1046\/j.1523-1755.2001.0590051670.x","volume":"59","author":"M Buzza","year":"2001","unstructured":"Buzza, M., Wilson, D. & Savige, J. Segregation of hematuria in thin basement membrane disease with haplotypes at the loci for Alport syndrome. Kidney Int. 59, 1670\u20131676 (2001).","journal-title":"Kidney Int."},{"key":"BFnrneph2010122_CR40","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1681\/ASN.2007040444","volume":"18","author":"K Voskarides","year":"2007","unstructured":"Voskarides, K. et al. COL4A3\/COL4A4 mutations producing focal segmental glomerulosclerosis and renal failure in thin basement membrane nephropathy. J. Am. Soc. Nephrol. 18, 3004\u20133016 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010122_CR41","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/00005792-199909000-00005","volume":"78","author":"CE Kashtan","year":"1999","unstructured":"Kashtan, C. E. Alport syndrome. An inherited disorder of renal, ocular, and cochlear basement membranes. Medicine (Baltimore) 78, 338\u2013360 (1999).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrneph2010122_CR42","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/j.1399-3046.2006.00528.x","volume":"10","author":"CE Kashtan","year":"2006","unstructured":"Kashtan, C. E. Renal transplantation in patients with Alport syndrome. Pediatr. Transplant. 10, 651\u2013657 (2006).","journal-title":"Pediatr. Transplant."},{"key":"BFnrneph2010122_CR43","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1681\/ASN.V52161","volume":"5","author":"J Ding","year":"1994","unstructured":"Ding, J., Zhou, J., Tryggvason, K. & Kashtan, C. E. COL4A5 deletions in three patients with Alport syndrome and posttransplant antiglomerular basement membrane nephritis. J. Am. Soc. Nephrol. 5, 161\u2013168 (1994).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010122_CR44","first-page":"508","volume":"116","author":"CE Kashtan","year":"1990","unstructured":"Kashtan, C. E., Butkowski, R. J., Kleppel, M. M., First, M. R. & Michael, A. F. Posttransplant anti-glomerular basement membrane nephritis in related males with Alport syndrome. J. Lab. Clin. Med. 116, 508\u2013515 (1990).","journal-title":"J. Lab. Clin. Med."},{"key":"BFnrneph2010122_CR45","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/00005792-200203000-00003","volume":"81","author":"MH Branton","year":"2002","unstructured":"Branton, M. H. et al. Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course. Medicine (Baltimore) 81, 122\u2013138 (2002).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrneph2010122_CR46","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/jmg.38.11.769","volume":"38","author":"KD MacDermot","year":"2001","unstructured":"MacDermot, K. D., Holmes, A. & Miners, A. H. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J. Med. Genet. 38, 769\u2013775 (2001).","journal-title":"J. Med. Genet."},{"key":"BFnrneph2010122_CR47","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1046\/j.1445-5994.2002.00291.x","volume":"32","author":"J Galanos","year":"2002","unstructured":"Galanos, J. et al. Clinical features of Fabry's disease in Australian patients. Intern. Med. J. 32, 575\u2013584 (2002).","journal-title":"Intern. Med. J."},{"key":"BFnrneph2010122_CR48","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1046\/j.1523-1755.2003.00160.x","volume":"64","author":"S Nakao","year":"2003","unstructured":"Nakao, S. et al. Fabry disease: detection of undiagnosed hemodialysis patients and identification of a \u201crenal variant\u201d phenotype. Kidney Int. 64, 801\u2013807 (2003).","journal-title":"Kidney Int."},{"key":"BFnrneph2010122_CR49","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1159\/000167493","volume":"7","author":"S Popli","year":"1987","unstructured":"Popli, S. et al. Involvement of renal allograft by Fabry's disease. Am. J. Nephrol. 7, 316\u2013318 (1987).","journal-title":"Am. J. Nephrol."},{"key":"BFnrneph2010122_CR50","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s00467-003-1289-8","volume":"18","author":"C Loirat","year":"2003","unstructured":"Loirat, C. & Niaudet, P. The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children. Pediatr. Nephrol. 18, 1095\u20131101 (2003).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2010122_CR51","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2215\/CJN.00050505","volume":"1","author":"E Bresin","year":"2006","unstructured":"Bresin, E. et al. Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background. Clin. J. Am. Soc. Nephrol. 1, 88\u201399 (2006).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrneph2010122_CR52","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1056\/NEJMra0902814","volume":"361","author":"M Noris","year":"2009","unstructured":"Noris, M. & Remuzzi, G. Atypical hemolytic-uremic syndrome. N. Engl. J. Med. 361, 1676\u20131687 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2010122_CR53","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","volume":"108","author":"J Caprioli","year":"2006","unstructured":"Caprioli, J. et al. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 108, 1267\u20131279 (2006).","journal-title":"Blood"},{"key":"BFnrneph2010122_CR54","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1136\/jmg.40.9.676","volume":"40","author":"HP Neumann","year":"2003","unstructured":"Neumann, H. P. et al. Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries. J. Med. Genet. 40, 676\u2013681 (2003).","journal-title":"J. Med. Genet."},{"key":"BFnrneph2010122_CR55","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1681\/ASN.2006080811","volume":"18","author":"AL Sellier-Leclerc","year":"2007","unstructured":"Sellier-Leclerc, A. L. et al. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. J. Am. Soc. Nephrol. 18, 2392\u20132400 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010122_CR56","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1399-3046.2008.00910.x","volume":"12","author":"C Loirat","year":"2008","unstructured":"Loirat, C. & Fremeaux-Bacchi, V. Hemolytic uremic syndrome recurrence after renal transplantation. Pediatr. Transplant. 12, 619\u2013629 (2008).","journal-title":"Pediatr. Transplant."},{"key":"BFnrneph2010122_CR57","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1111\/j.1600-6143.2008.02297.x","volume":"8","author":"M Le Quintrec","year":"2008","unstructured":"Le Quintrec, M. et al. Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation. Am. J. Transplant. 8, 1694\u20131701 (2008).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2010122_CR58","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1681\/ASN.2005010103","volume":"16","author":"D Kavanagh","year":"2005","unstructured":"Kavanagh, D. et al. Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome. J. Am. Soc. Nephrol. 16, 2150\u20132155 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010122_CR59","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1681\/ASN.2008080906","volume":"20","author":"JM Saland","year":"2009","unstructured":"Saland, J. M., Ruggenenti, P. & Remuzzi, G. Liver-kidney transplantation to cure atypical hemolytic uremic syndrome. J. Am. Soc. Nephrol. 20, 940\u2013949 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010122_CR60","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1681\/ASN.2005101051","volume":"17","author":"V Fremeaux-Bacchi","year":"2006","unstructured":"Fremeaux-Bacchi, V. et al. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. J. Am. Soc. Nephrol. 17, 2017\u20132025 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010122_CR61","doi-asserted-by":"publisher","first-page":"12966","DOI":"10.1073\/pnas.2135497100","volume":"100","author":"A Richards","year":"2003","unstructured":"Richards, A. et al. Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proc. Natl Acad. Sci. USA 100, 12966\u201312971 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneph2010122_CR62","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1053\/j.ajkd.2008.06.027","volume":"53","author":"MR Chan","year":"2009","unstructured":"Chan, M. R. et al. Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient. Am. J. Kidney Dis. 53, 321\u2013326 (2009).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2010122_CR63","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1046\/j.1523-1755.2000.00250.x","volume":"58","author":"M Levy","year":"2000","unstructured":"Levy, M. & Feingold, J. Estimating prevalence in single-gene kidney diseases progressing to renal failure. Kidney Int. 58, 925\u2013943 (2000).","journal-title":"Kidney Int."},{"key":"BFnrneph2010122_CR64","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/BF01957682","volume":"149","author":"K Latta","year":"1990","unstructured":"Latta, K. & Brodehl, J. Primary hyperoxaluria type I. Eur. J. Pediatr. 149, 518\u2013522 (1990).","journal-title":"Eur. J. Pediatr."},{"key":"BFnrneph2010122_CR65","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1681\/ASN.V12102072","volume":"12","author":"A Amoroso","year":"2001","unstructured":"Amoroso, A. et al. AGXT gene mutations and their influence on clinical heterogeneity of type 1 primary hyperoxaluria. J. Am. Soc. Nephrol. 12, 2072\u20132079 (2001).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010122_CR66","first-page":"593","volume":"87","author":"RW Watts","year":"1994","unstructured":"Watts, R. W. Primary hyperoxaluria type I. QJM 87, 593\u2013600 (1994).","journal-title":"QJM"},{"key":"BFnrneph2010122_CR67","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1097\/TP.0b013e3181a27939","volume":"87","author":"F Brinkert","year":"2009","unstructured":"Brinkert, F. et al. Transplantation procedures in children with primary hyperoxaluria type 1: outcome and longitudinal growth. Transplantation 87, 1415\u20131421 (2009).","journal-title":"Transplantation"},{"key":"BFnrneph2010122_CR68","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1097\/01.TP.0000084203.76110.AC","volume":"76","author":"MT Millan","year":"2003","unstructured":"Millan, M. T. et al. One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: a single-center experience. Transplantation 76, 1458\u20131463 (2003).","journal-title":"Transplantation"},{"key":"BFnrneph2010122_CR69","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1046\/j.1523-1755.1999.00619.x","volume":"56","author":"P Saborio","year":"1999","unstructured":"Saborio, P. & Scheinman, J. I. Transplantation for primary hyperoxaluria in the United States. Kidney Int. 56, 1094\u20131100 (1999).","journal-title":"Kidney Int."},{"key":"BFnrneph2010122_CR70","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/BF00864408","volume":"7","author":"P Cochat","year":"1993","unstructured":"Cochat, P. & Scharer, K. Should liver transplantation be performed before advanced renal insufficiency in primary hyperoxaluria type 1? Pediatr. Nephrol. 7, 212\u2013218 (1993).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2010122_CR71","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1056\/NEJM199806253382615","volume":"338","author":"RW Gruessner","year":"1998","unstructured":"Gruessner, R. W. Preemptive liver transplantation from a living related donor for primary hyperoxaluria type I. N. Engl. J. Med. 338, 1924 (1998).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2010122_CR72","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1111\/j.1523-1755.2005.00267.x","volume":"67","author":"CG Monico","year":"2005","unstructured":"Monico, C. G., Rossetti, S., Olson, J. B. & Milliner, D. S. Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele. Kidney Int. 67, 1704\u20131709 (2005).","journal-title":"Kidney Int."},{"key":"BFnrneph2010122_CR73","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/j.1523-1755.2004.00796.x","volume":"66","author":"C van Woerden","year":"2004","unstructured":"van Woerden, C. S. et al. Clinical implications of mutation analysis in primary hyperoxaluria type 1. Kidney Int. 66, 746\u2013752 (2004).","journal-title":"Kidney Int."},{"key":"BFnrneph2010122_CR74","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/ki.1984.93","volume":"25","author":"JI Scheinman","year":"1984","unstructured":"Scheinman, J. I., Najarian, J. S. & Mauer, S. M. Successful strategies for renal transplantation in primary oxalosis. Kidney Int. 25, 804\u2013811 (1984).","journal-title":"Kidney Int."},{"key":"BFnrneph2010122_CR75","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1053\/jlts.2003.50072","volume":"9","author":"I Astarcioglu","year":"2003","unstructured":"Astarcioglu, I. et al. Primary hyperoxaluria: simultaneous combined liver and kidney transplantation from a living related donor. Liver Transpl. 9, 433\u2013436 (2003).","journal-title":"Liver Transpl."},{"key":"BFnrneph2010122_CR76","doi-asserted-by":"publisher","first-page":"427.e7","DOI":"10.1016\/j.urology.2006.02.035","volume":"68","author":"GS Rosenblatt","year":"2006","unstructured":"Rosenblatt, G. S., Jenkins, R. D. & Barry, J. M. Treatment of primary hyperoxaluria type 1 with sequential liver and kidney transplants from the same living donor. Urology 68, 427.e7\u2013427.e8 (2006).","journal-title":"Urology"},{"key":"BFnrneph2010122_CR77","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1399-3046.2005.00297.x","volume":"9","author":"TC Jungraithmayr","year":"2005","unstructured":"Jungraithmayr, T. C. et al. Primary focal segmental glomerulosclerosis\u2014long-term outcome after pediatric renal transplantation. Pediatr. Transplant. 9, 226\u2013231 (2005).","journal-title":"Pediatr. Transplant."},{"key":"BFnrneph2010122_CR78","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF01453669","volume":"5","author":"JS Cameron","year":"1991","unstructured":"Cameron, J. S. Recurrent primary disease and de novo nephritis following renal transplantation. Pediatr. Nephrol. 5, 412\u2013421 (1991).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2010122_CR79","first-page":"489","volume":"14","author":"R Habib","year":"1982","unstructured":"Habib, R., Hebert, D., Gagnadoux, M. F. & Broyer, M. Transplantation in idiopathic nephrosis. Transplant. Proc. 14, 489\u2013495 (1982).","journal-title":"Transplant. Proc."},{"key":"BFnrneph2010122_CR80","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S0272-6386(12)80172-7","volume":"24","author":"EL Ramos","year":"1994","unstructured":"Ramos, E. L. & Tisher, C. C. Recurrent diseases in the kidney transplant. Am. J. Kidney Dis. 24, 142\u2013154 (1994).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2010122_CR81","first-page":"S44","volume":"19","author":"JE Striegel","year":"1986","unstructured":"Striegel, J. E., Sibley, R. K., Fryd, D. S. & Mauer, S. M. Recurrence of focal segmental sclerosis in children following renal transplantation. Kidney Int. Suppl. 19, S44\u2013S50 (1986).","journal-title":"Kidney Int. Suppl."},{"key":"BFnrneph2010122_CR82","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s00467-004-1676-9","volume":"19","author":"P Niaudet","year":"2004","unstructured":"Niaudet, P. Genetic forms of nephrotic syndrome. Pediatr. Nephrol. 19, 1313\u20131318 (2004).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2010122_CR83","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1523-1755.2004.00776.x","volume":"66","author":"S Weber","year":"2004","unstructured":"Weber, S. et al. NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int. 66, 571\u2013579 (2004).","journal-title":"Kidney Int."},{"key":"BFnrneph2010122_CR84","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/74166","volume":"24","author":"N Boute","year":"2000","unstructured":"Boute, N. et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat. Genet. 24, 349\u2013354 (2000).","journal-title":"Nat. Genet."},{"key":"BFnrneph2010122_CR85","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1681\/ASN.V12122742","volume":"12","author":"G Caridi","year":"2001","unstructured":"Caridi, G. et al. Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis. J. Am. Soc. Nephrol. 12, 2742\u20132746 (2001).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010122_CR86","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/j.1600-6143.2006.01605.x","volume":"7","author":"R Becker-Cohen","year":"2007","unstructured":"Becker-Cohen, R. et al. Recurrent nephrotic syndrome in homozygous truncating NPHS2 mutation is not due to anti-podocin antibodies. Am. J. Transplant. 7, 256\u2013260 (2007).","journal-title":"Am. J. Transplant."},{"key":"BFnrneph2010122_CR87","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/S0272-6386(03)00364-0","volume":"41","author":"R Bertelli","year":"2003","unstructured":"Bertelli, R. et al. Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. Am. J. Kidney Dis. 41, 1314\u20131321 (2003).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrneph2010122_CR88","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00467-003-1408-6","volume":"19","author":"H Billing","year":"2004","unstructured":"Billing, H. et al. NPHS2 mutation associated with recurrence of proteinuria after transplantation. Pediatr. Nephrol. 19, 561\u2013564 (2004).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2010122_CR89","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1007\/s00467-006-0148-9","volume":"21","author":"B H\u00f6cker","year":"2006","unstructured":"H\u00f6cker, B. et al. Recurrence of proteinuria 10 years post-transplant in NPHS2-associated focal segmental glomerulosclerosis after conversion from cyclosporin A to sirolimus. Pediatr. Nephrol. 21, 1476\u20131479 (2006).","journal-title":"Pediatr. Nephrol."},{"key":"BFnrneph2010122_CR90","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1097\/01.ASN.0000113552.59155.72","volume":"15","author":"R Ruf","year":"2004","unstructured":"Ruf, R. G. et al. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J. Am. Soc. Nephrol. 15, 722\u2013732 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrneph2010122_CR91","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/ki.2008.650","volume":"75","author":"E Machuca","year":"2009","unstructured":"Machuca, E. et al. Clinical and epidemiological assessment of steroid-resistant nephrotic syndrome associated with the NPHS2 R229Q variant. Kidney Int. 75, 727\u2013735 (2009).","journal-title":"Kidney Int."},{"key":"BFnrneph2010122_CR92","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1172\/JCI0216242","volume":"110","author":"H Tsukaguchi","year":"2002","unstructured":"Tsukaguchi, H. et al. NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele. J. Clin. Invest. 110, 1659\u20131666 (2002).","journal-title":"J. Clin. Invest."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2010.122.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2010.122","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2010.122.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:33:10Z","timestamp":1684456390000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2010.122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,28]]},"references-count":92,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["BFnrneph2010122"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2010.122","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,28]]}}}